article thumbnail

Boosting Wearable Compliance in Parkinson’s Studies

Scienmag

However, a persistent challenge lingers: ensuring consistent patient compliance in wearing these devices. Their work goes beyond merely identifying compliance rates; it delves deep into behavioral patterns, psychological motivators, and physical barriers that either facilitate or hinder continual device use.

article thumbnail

AI-powered orchestration: Bringing the benefits to personalized therapy

Pharmaceutical Technology

Supply chains for a new generation of therapies are complex, costly, and require meticulous management to ensure patient safety and regulatory compliance. AI can transform cell and gene therapy (CGT) orchestration by automating manual processes, improving productivity, enhancing supply chain visibility and improving scalability.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

AI in Pharma Marketing: Innovation or Compliance Nightmare?

Pharma Marketing Network

But as pharma marketers race to adopt these tools, a central question looms: Is AI fueling smarter engagement, or setting the stage for a compliance disaster? Efficiency Gains : Generative AI tools can streamline content productionsaving time on medical writing, compliance reviews, and campaign development. Key pillars include: 1.

article thumbnail

How to Ensure Compliance in Generic Drug Development

Drug Patent Watch

"Compliance in Generic Drug Development: A Critical Component of Success As the generic drug industry continues to grow, ensuring compliance with regulatory requirements has become a top priority for pharmaceutical companies.

article thumbnail

Can Your Organization Spot a Conflict Before It’s a Crisis?

Speaker: Amie Phillips Pablo, VP, Corporate Compliance & Privacy Officer at Novo Nordisk

Left unmanaged, these conflicts can compromise trust, regulatory compliance, and even organizational reputation. In today’s complex healthcare environment, navigating third-party relationships has become even more challenging—whether it’s vendor relationships, employee activities, or patient-facing interactions.

article thumbnail

Biopharma & medical devices cos view advanced infrastructure to propel manufacturing & new drug development

AuroBlog - Aurous Healthcare Clinical Trials blog

It ensures scalability, quality control, and regulatory compliance. By investing in advanced labs, manufacturing facilities, regulatory compliance systems, cybersecurity, and global supply chains, companies can ensure they meet […]

article thumbnail

Morale at the FDA Has Hit Rock Bottom: What It Means for Pharma

World of DTC Marketing

Communication Breakdown Low morale can contribute to inconsistent and unclear communications from FDA reviewers and compliance officers. Increased Compliance Scrutiny When agency morale dips, there is typically a heightened sensitivity around compliance. Morale at the FDA isn’t merely an internal matter.

article thumbnail

How to Turn “Check-the-Box” Compliance Trainings Into Real Learning

Speaker: Brian Richardson, Brian Richardson, Founder and CEO of Richardson Consulting Group

Let’s face it—most ethics and compliance training programs aren’t winning awards for engagement. Join learning design expert Brian Richardson for a dynamic session on how to breathe new life into your ethics and compliance training. But that doesn’t mean they can’t be effective, captivating, and maybe even enjoyable!